As shopping gets more digital, demand for industrial space is expected to explode. How can you play this trend? Read More...
Motley Fool
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
Looking for investment opportunities in the healthcare sector, and particularly in the biotechnology industry, can be overwhelming if you’re not intimately familiar with the space. Here are three companies that operate surprisingly diverse operations — either through drug pipeline variety, customer diversification, or differentiated product verticals — offering a safety net, as well as prospects for growth, to their shareholders as a result. Led by its mission “to help people access, understand, and benefit from the human genome,” 23andMe Holding (NASDAQ: ME) has quietly identified over 40 therapeutic programs from its treasure trove of genetic data.
Add Comment